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Abstract. Bluetongue (BT) is a vector-borne viral disease of ruminants. The infection is widespread globally with major
implications for international animal trade and production. In 2006, BT virus serotype 8 (BTV-8) was encountered in Europe
for the first time, causing extensive production losses and death in susceptible livestock. Following the appearance of BTV-
8 in Switzerland in 2007, a compulsory vaccination programme was launched in the subsequent year. Due to social factors
and difficulties to reach animals on high pasture, the regional vaccination coverage varied across the country in both 2008
and 2009. In this study, the effect of vaccination on the spatial occurrence of BTV-8 and the associated relative disease risk
in Switzerland in 2008 and 2009 were investigated by a spatial Bayesian hierarchical approach. Bayesian posterior distri-
butions were obtained by integrated nested Laplace approximations, a promising alternative to commonly used Markov
chain Monte Carlo methods. The number of observed BTV-8 outbreaks in Switzerland decreased notably from 2008 to
2009. However, only a non-significant association between vaccination coverage and the probability of a spatial unit being
infected with BTV-8 was identified using the model developed for this study. The relative disease risk varied significantly
across the country, with a higher relative risk of BTV-8 infection in western and north-western Switzerland where environ-
mental conditions are more suitable for vector presence and viral transmission. Examination of the spatial correlation
between disease occurrence, control measures and associated ecological factors can be valuable in the evaluation and devel-
opment of disease control programmes, allowing prioritisation of areas with a high relative risk of disease.
Keywords: Bayesian hierarchical model, bluetongue, disease mapping, integrated nested Laplace approximation, vaccina-
tion,, Switzerland.
Introduction
Bluetongue (BT) is a non-contagious, arboviral dis-
ease of ruminants. The disease causes extensive eco-
nomic losses in the livestock production sector and is
listed as a notifiable disease by the World
Organisation for Animal Health (OIE) (Mellor and
Wittmann, 2002; Mintiens et al., 2008; Saegerman et
al., 2008). The mortality rate can be as high as
50-70% in certain sheep breeds (Sellers, 1984; Elbers
et al., 2008b) and infected countries are imposed with
trade restrictions (Méroc et al., 2008). The aetiologi-
cal agent of BT, bluetongue virus (BTV), belongs to the
family Reoviridae and the genus Orbivirus (Mellor
and Wittmann, 2002; Purse et al., 2005). At the pres-
ent time, there are 24 recognised serotypes of BTV and
a putative 25th serotype has been identified in goats
(Hofmann et al., 2008; Saegerman et al., 2008). The
clinical implications of BTV infection can range from
asymptomatic to severe or even death. BT infection
tends to be more pronounced in sheep than other
domestic ruminants, such as cattle, where the disease
often is sub-clinical (Sellers, 1984; Elbers et al., 2008a;
Vellema, 2008). 
The geographical distribution of BT is restricted to
areas where there are susceptible animal hosts, com-
petent vector species and suitable climatic conditions
for viral transmission (Mellor et al., 2000; Mellor
and Wittmann, 2002; Saegerman et al., 2008). BT is
transmitted by biting midges of the genus Culicoides
(Mellor and Wittmann, 2002; Purse et al., 2005).
Climatic and environmental conditions, such as tem-
perature, humidity and access to breeding sites limit
the vector distribution (Sellers, 1984; Purse et al.,
2005; Saegerman et al., 2008). In addition, BTV
replication in the vector and host is temperature
dependent and, although the vector can be active at
temperatures above 10 ˚C, viral replication in the
vector becomes prominent at temperatures above 15-
18 ˚C (Mellor, 2000; Wittmann et al., 2002; EFSA,
2007). 
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In August 2006, BTV-8 emerged in the Netherlands,
a serotype of BTV that had previously not been
recorded in Europe (Elbers et al., 2008a; Mintiens et
al., 2008). The infection spread rapidly across Europe
in 2007 and 2008. Thus, when commercial inactivat-
ed vaccines against BTV-8 became available in 2008,
several affected countries launched national vaccina-
tion campaigns in order to control the disease
(Gethmann et al., 2009; Roy et al., 2009). Following
the outbreak of BTV-8 in northern Europe in 2006,
BT surveillance in Switzerland was intensified and
increased disease awareness was encouraged among
livestock keepers (Kluiters et al., 2008). For surveil-
lance purposes, Switzerland was divided into 16
regions, hereafter referred to as BT-regions, based on
animal population numbers, land area and adminis-
trative boundaries. The Principality of Liechtenstein
composed a 17th BT-region (Figure 1; Kluiters et al.,
2008). The first case of BTV-8 in Switzerland was
detected in October 2007 (Hofmann et al., 2008).
Switzerland initiated a vaccination campaign against
BTV-8 in June 2008 with mandatory vaccination of
cattle, sheep and goats (FVO, 2009). The vaccination
campaign continued in 2009 with compulsory vacci-
nation of cattle and sheep above 3 months of age
(FVO, 2009). The vaccination programme was imple-
mented locally by the cantonal veterinary offices and,
consequently, the vaccination coverage varied region-
ally in both years, ranging from 24% to 82%.
The effect of vaccination on the disease prevalence
in a population depends on the achieved vaccination
coverage, characteristics of the disease and attributes
of the targeted group (Anderson and May, 1982).
Simulation models show that both the incidence and
spatial spread of BTV-8 decrease with increasing vac-
cination coverage (Szmaragd et al., 2010a,b). By using
adequate spatial models, the spatial association
between disease management measures or ecological
factors and disease prevalence can be explored. We
applied a spatial Bayesian hierarchical approach to
examine the spatial heterogeneity in relative disease
risk and to investigate the association between BTV-8
occurrence and vaccination coverage in Switzerland in
2008 and 2009, while controlling for spatial variation
in surveillance intensity. Since vaccination of suscepti-
ble animals reduces virus transmission and the proba-
bility of an animal acquiring infection (Szmaragd et
al., 2010b), a negative correlation between vaccina-
tion coverage and the probability of a unit being
infected with BTV-8 in a spatially defined area was
expected. 
Materials and methods
Study area and study population
Switzerland is a federal state, consisting of 20 can-
tons and six half cantons. The country covers an area
of 41,285 km2 and is located north of latitude 46º N
in central Europe. In the south, Switzerland is divided
by the Alps with a maximum altitude of 4,700 m
above sea level. Out of the total land area, 37% is
used for agricultural purposes. Family driven farming
enterprises are most predominant, with milk being the
main product of livestock keeping.
The number of cattle farms and registered cattle on
Fig. 1. Hillshade map of Switzerland showing the division of the Swiss cantons and Liechtenstein (FL) by their abbreviated names
into 17 bluetongue regions.
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the 1st of May in 2008 and 2009 were obtained from
the Swiss Animal Movement Database
(Tierverkehrsdatenbank TVD) and included in the
study as the population at risk (2008: n = 1,628,435
animals/44,559 farms; 2009: n = 1,642,613 ani-
mals/44,202 farms). Since official disease control
measures are applied locally by the cantonal veterinary
authorities, animal and farm data were first consid-
ered at a regional level by aggregating animal data
(“animal aggregated data”) and farm data (“farm
aggregated data”) for each BT-region. Secondly, point-
referenced data of each farm were analysed with
explanatory variables specific to the location of the
farm (“point-referenced data”).
A total of 42,081 farms (90.7%) were given
Cartesian coordinates based on their TVD identifica-
tion number. If no geographical coordinates were
available, farms were assigned the centroid coordi-
nates of their community. ArcGIS version 9.2 (ESRI;
Redlands, CA, USA) was used to map and manage
spatial information. Geographical coordinates of
farms were referenced in the Swiss reference system
CH1903. For the regional analysis, the geographical
coordinates of each farm were spatially joined to a
shapefile of the 17 BT-regions in order to estimate the
population at risk per BT-region. In the analysis of
point-referenced data, 4,323 farms (9.3%) were
excluded from the population at risk since they lacked
geographical point coordinates. For farms included in
the analysis of point-referenced data, the farm altitude
(m above sea level) was extracted from raster elevation
map DHM25 (Federal Office of Topography swis-
stopo) with a spatial resolution of 5 x 5 m.
Disease data
BTV-8 case data of cattle from 2008 and 2009 were
extracted from the Swiss database of notifiable dis-
eases (InfoSM) maintained by the Federal Veterinary
Office (FVO). Since different surveillance activities
may target separate characteristics of the population
and disease (Del Rio Vilas and Pfeiffer, 2009), data
from three simultaneous but independent surveillance
programmes were included in the analysis: reported
cases of clinical suspicion, official targeted surveillance
where 10 cattle from 20 randomly selected farms of
each BT-region were sampled in February to March
each year (FVO, 2009), and pre-movement testing.
For pre-movement tested animals, the animal identifi-
cation number was linked to the TVD database in
order to identify the last farm location. Data were
aggregated annually since the time delay in reporting
disease following infection of an animal may vary.
Moreover, the time of infection of sub-clinical cases
detected through the official surveillance programme
and pre-movement testing is unknown. Seeing that
BTV infection generally is not detected in cattle herds
until 2 months after the beginning of the vector active
season (Bishop et al., 2004, Conraths et al., 2009),
which in Switzerland was in April in both 2008 and
2009 (FVO, 2009), cases detected through the official
surveillance programme or pre-movement testing
before the 1st of June were assumed to belong to the
previous BT season.
An animal was considered BTV-8 positive if it had a
positive polymerase chain reaction (PCR) result for
BTV-8 from the national reference laboratory for BT,
the Institute of Virology and Immunoprophylaxis (IVI;
Mittelhäusern). A farm was regarded BTV-8 positive if
at least one positive animal was detected at the farm.
The diagnostic method was assumed to be 100% sen-
sitive and specific. 
Vaccination data
Yearly BTV-8 vaccination data of cattle were
acquired from FVO. An animal was considered vacci-
nated against BTV-8 following two vaccine doses
administrated within an interval of 21 to 63 days. A
farm was regarded vaccinated if at least one animal at
that farm had been vaccinated. Vaccine efficacy was
assumed to be 100%. Any delays in reaching full pro-
tection were neglected.
Spatial modelling
Analysis of regionally aggregated data. 
To estimate the relative risk of one unit being infect-
ed at a regional level, a spatial and spatio-temporal
disease mapping model constructed in a Bayesian hier-
archical framework was developed. Three hierarchical
stages were specified as explained by Clayton and
Bernardinelli (1992). The first stage describes the
observed data, in this case the number of infected units
per BT-region, as a function of the region-specific rel-
ative risk of disease. At stage two, the relative risk of
disease for each region is modelled. The hyperpriors
for all variance parameters of stage two are specified
at stage three. It was assumed that the number of
infected units yi in a region i (i = 1, ..., 17) has a
Poisson distribution: 
yi ~ Poisson (λi · ni) (1)
K.J.E. Willgert et al. - Geospatial Health 5(2), 2011, pp. 227-237230
where λi is the probability of one unit, either animal
or farm, being BTV-8 infected in region i, and ni the
population at risk in each BT-region. The relative risk
parameter λi, described by Besag et al. (1991), is spec-
ified using a linear predictor:
ηi = log (λi) = µ + νi + ψi (2)
where µ is the intercept. The regional term νi and glob-
al term ψi account for any unmeasured explanatory
variables considered in the model (Clayton et al.,
1993). The term νi is a spatially unstructured variable
that accounts for unmeasured risk factors that vary
between areas, whereas ψi is assumed to be structured
in space and models the effect of the location, account-
ing for the assumption that geographically close areas
are more related than distant areas (Clayton et al.,
1993; Durr et al., 2005). Hence, the regional term νi
was modelled as an independent identically (i.i.d.) nor-
mal distributed random effect, while the global term ψi
was modelled as a so-called intrinsic Gaussian Markov
random field (IGMRF) of first order on an irregular
lattice (Rue and Held, 2005). Such an IGMRF
accounts for spatial autocorrelation by assuming that
the conditional distribution of ψi in region i depends on
the ψj in neighbouring regions j. An adjacency matrix
of the BT-regions was constructed, where neighbours
of each region, defined by a shared common boundary,
were counted and listed. To all variances, an inverse
gamma hyper-prior IGa (1.0, 0.01) was assigned
(Bernardinelli et al., 1995a). To account for any addi-
tional over-dispersion, the data could be modelled
using a negative binomial distribution (Gschössl and
Czado, 2008), which includes an additional dispersion
parameter. However, the deviance information criteri-
on (DIC) (Spiegelhalter, 2002) was higher for all mod-
els assuming a negative binomial distribution than for
the corresponding Poisson models, indicating that a
Poisson distribution was sufficient for this study.
Two region-specific explanatory covariates were
included in the analysis to account for any spatial vari-
ation in relative disease risk: vaccination coverage
(vacc_covi), calculated as the number of units vacci-
nated divided by the total number of units, and sur-
veillance intensity (surv_inti), estimated by dividing the
number of tested units by the total number of units:
ηi = log (λi) = µ + β1 · vacc_covi +
+ β2 · surv_inti + νi + ψi (3)
where β denotes a fixed linear effect of the explanatory
variable. The surveillance intensity in each region was
included to assure that any variation in estimated disease
risk was not the product of regionally differing surveil-
lance efforts. Since the cantonal veterinary services
implement legislation of animal health at a local level
(Rüsch and Kihm, 2003), the surveillance intensity
varies regionally and reporting of suspected disease may
be biased in space and time by varying disease awareness
(Kluiters et al., 2008; Del Rio Vilas and Pfeiffer, 2009).
Due to the sparsity of BTV-8 positive cases in 2009,
a spatial analysis was only conducted for 2008. To
assess if there was any significant change in the prob-
ability of a unit being infected between 2008 and
2009, a spatio-temporal disease mapping model was
adopted. A random intercept γt for each year t was
added to formula (3) (Knorr-Held, 2000): 
ηit = log (λit) = µ + β1 · vacc_covi + 
+ β2 · surv_inti + νi + ψi + γt (4)
This is a version of the standard non-parametric
space-time model introduced by Knorr-Held (2000).
Since the data considered were restricted to 2 years, a
random intercept for each time point was preferred to
a linear trend (Bernardinelli et al., 1995b). Due to the
sparseness of BTV-8 cases, especially in 2009, any
interactions between space and time were neglected.
An inverse gamma hyper-prior IGa (1.0, 0.01) was
assigned to the variance of γt.
The four mountain BT-regions Bern south (BE
South), Valais (VS), Ticino (TI) and Grisons (GR)
(Fig. 1) were excluded from the analysis at regional
level since the risk factors associated with BT are
believed to differ considerably from the rest of the
country in these areas due to the distinct environ-
mental conditions observed in the Alps (Racloz et
al., 2008). In the Alps, the microclimate varies with-
in short distances, making it difficult to form a
covariate that is valid for the whole region to adjust
for the local environmental conditions.
Analysis of point-referenced data. 
For the analysis of point-referenced farm data, a
generalised Bayesian geoadditive model was adopted
(Kneib and Fahrmeir, 2006; Musio et al., 2008), where
the exact location of the unit in space is known. The
location of each farm in terms of easting and northing
was denoted as sij. Since farms can be either BTV-8
positive or negative, it was assumed that the response
yij followed a binomial distribution:
yij ~ Binom (πij , 1) (5)
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where πij denotes the probability of a farm at location
sij being infected, modelled by a latent Gaussian field
of the form:
ηij = logit (πij) = µ + β1 · vacc_covij +
+ β2 · surv_intij + f(sij) (6)
where the vaccination coverage (vacc_covij) was given
the value 1 if at least one animal at the farm had been
vaccinated and otherwise zero. To account for varying
surveillance efforts within the study area, a 0-1-index
for the surveillance intensity (surv_intij) was also
included as an explanatory variable. The location effect
f of each farm was modelled as a Gaussian Markov
random field on a two-dimensional lattice (Rue and
Held, 2005). The easting and northing of each farm
were assigned to a regular grid with I rows and J
columns (Besag and Kooperberg, 1995), where I = 100
and J = 80 based on the shape of Switzerland. An
intrinsic second order random walk prior was adopted
(Rue and Held, 2005), where the full conditional mean
of a node (i,j) on the grid depends on the four direct
neighbours on the grid, the four diagonal neighbours
on the grid and the four direct neighbours of second
order. Hence, a node (i,j) borrows strength from its 12
closest spatial neighbours. The size of the residual spa-
tial effect is controlled by the variance, σf2. An inverse
gamma hyper-prior IGa (1.0, 0.01) was assigned to σf2. 
Due to the scarcity of BTV-8 cases, a linear spatial
trend surface was also adapted with a linear predictor
defined as: 
ηij = logit (πij) = µ + β1 · vacc_covij +
+ β2 · surv_intij + β4 · i + β5 · j (7)
where the indexes i and j denote the location of a farm
on the spatial lattice. The conditional mean of each farm
depends on the average response of the farms in the same
row and the same column. This formulation gives a
more global east-west and north-south effect compared
to the more localized, autoregressive two-dimensional
second order random walk discussed previously.
In contrast to the aggregated data, the exact altitude
(altitudeij) of each farm is known and can be put into
model (7) as an indicator of temperature dependent
dynamics of the vector population and viral replica-
tion:
ηij = logit (πij) = µ + β1 · vacc_covij + β2 · surv_intij
+ β3 · altitudeij + β4 · i + β5 · j (8)
Since this model is able to, at least partly, adjust for
different environmental conditions in mountain areas,
all data were used for this analysis.
Model choice and computation
Models were compared and selected using DIC,
which takes into consideration the posterior mean
deviance, a Bayesian measure of model fit, and the
complexity of the model. A smaller DIC indicates a
better fit of the model (Spiegelhalter, 2002).
All models were computed using integrated nested
Laplace approximations (INLA), a recently proposed
method for approximate Bayesian inference within
latent Gaussian models. INLA has various applica-
tions, ranging from generalized mixed models to
dynamic and spatio-temporal models (Rue et al.,
2009; Schrödle and Held, 2010). Furthermore, INLA
outperforms traditional Markov chain Monte Carlo
(MCMC) methods in terms of computational time
while providing very precise estimates (Rue et al.,
2009). The analyses can be conducted within a pow-
erful R environment (R Development Core Team,
2010) using the R-INLA package available at www.r-
inla-org.  All analyses in this study were run using the
R-INLA version built on 22 October 2010.
Results
A total of 69 BTV-8 infected holdings and 131 BTV-
8 infected cattle were recorded in 2008. Three affect-
ed holdings with one infected animal each were docu-
mented in 2009 (Fig. 2). Summary statistics for the 17
BT-regions are displayed in Table 1. 
Parameter results of regional disease mapping models
For all regional models, the posterior distribution of
the fixed effect of vaccination had a negative posterior
mean (Table 2), suggesting that increasing vaccination
coverage reduced the probability of a unit being infect-
ed. However, all credible intervals contained the value
zero, meaning that the model did not identify a signif-
icant association between the level of regional vacci-
nation and the probability of a unit being infected. 
The number of tested units from reported cases of
clinical suspicion, official targeted surveillance and
pre-movement testing was used to estimate the sur-
veillance intensity. In both the spatial and spatio-tem-
poral regional models, the fixed effect of the surveil-
lance intensity was not significant for the animal
aggregated data, but showed a significant positive pos-
terior mean when farm aggregated data were used
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Fig. 2. Maps of Switzerland showing the spatial distribution of BTV-8 infected units recorded in 2008 (n) and 2009 (5). Proportional
symbol map of the number of BTV-8 infected cattle, ranging from 1 to 11, at each affected farm (a); and BTV-8 infected farms (b).
Table 1. Summary statistics at animal level and farm level for the 17 bluetongue regions of the population at risk (n), the number
of detected positive BTV-8 cases (y) and vaccination coverage (vacc) in Switzerland in 2008 and 2009. 
(a) (b)
BT-region Animals Farms
2008 2009 2008 2009
n y Vacc (%) n y Vacc (%) n y Vacc (%) n y Vacc (%)
FL
AG
AI AR SG
BS BL SO
FR
GE VD
GR
JU NE
LU
TG
TI
UR GL ZG
VS
ZH SH
BE North
BE Central
BE South
5,683
91,801
181,773
74,302
140,714
121,871
76,404
102,520
152,574
74,962
10,321
122,130
32,327
110,837
79,973
185,990
64,253
0
0
12
1
17
9
3
22
17
0
0
33
1
4
6
4
2
69
72
65
73
50
52
37
68
73
70
29
70
32
72
59
64
24
6,073
91,913
183,127
74,557
142,654
123,545
77,998
104,757
152,536
75,501
10,512
121,679
32,826
111,857
80,593
188,854
63,631
0
0
0
1
1
0
0
0
1
0
0
0
0
0
0
0
0
82
72
71
77
79
78
78
78
78
77
71
52
67
71
71
77
70
102
2,180
5,052
1,828
2,763
2,575
2,126
1,766
4,492
1,912
455
4,064
1,537
2,686
2,072
6,516
2,433
0
0
9
1
9
5
3
11
4
0
0
12
1
4
4
4
2
78
93
88
94
79
79
49
91
94
89
34
88
50
93
89
92
40
107
2,157
5,042
1,803
2,754
2,551
2,113
1,775
4,461
1,891
444
4,035
1,521
2,654
2,024
6,471
2,399
0
0
0
1
1
0
0
0
1
0
0
0
0
0
0
0
0
88
92
91
93
89
88
87
92
94
93
74
86
82
94
88
94
89
Table 2. The estimated posterior mean and the 95% posterior credible interval, given as the estimated 2.5% and 97.5% quantiles,
of the vaccination coverage (β1) and the surveillance intensity (β2) at animal level and farm level of the spatial model (3) and spa-
tio-temporal model (4). 
Spatial model (3) Spatio-temporal model (4)
2.5% Mean 97.5% 2.5% Mean 97.5%
(a) Animals
β1
β2
(b) Farm
β1
β2
-14.59
-56.05
-8.51
12.34
-4.30
5.79
-2.61
32.37
4.61
67.51
3.30
52.68
-4.97
-52.74
-8.00
16.50
-0.25
8.99
-2.18
37.12
4.80
70.58
3.76
58.10
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(Table 2), supporting that there is a positive associa-
tion between surveillance intensity and the number of
infected farms detected, but a less strong association
between surveillance intensity and the number of
infected animals detected. 
The estimated random intercept for time on a log
scale decreased by 3.62 for the animal aggregated data
and by 1.71 for the farm aggregated data from 2008 to
2009, supporting that there was a significant change in
BTV-8 prevalence from 2008 to 2009. However, when
the temporal intercept was removed from model (4)
(animals: DIC = 86.4; farms: DIC = 80.1) to investigate
whether the decrease in prevalence of BTV-8 could be
explained by the vaccination coverage alone, the DIC
increased (animals: DIC = 212.7; farms: DIC = 92.5),
suggesting that the improved vaccination coverage in
2009 was not sufficient to explain the temporal
change in relative risk of a unit being infected.
The estimated relative risk of a unit being infected in
2008 after accounting for regional vaccination cover-
age and surveillance intensity is presented in Figure 3.
The spatial variation between BT-regions was quite
large for the models using animal aggregated data,
while the range of the residual spatial risk of the farm
disease mapping models was narrower, indicating that
the models explain most spatial variation in relative
disease risk at farm level after adjusting for regional
vaccination and surveillance intensity. 
Parameter results of geoadditive Bayesian models
Based on the DIC, the linear spatial trend model (7)
(DIC = 501.0) showed a better prediction than model
(6) assuming a localized second order random walk
(DIC = 507.6), and the latter was, therefore, not con-
sidered further. 
The estimated effects of the fixed coefficients of
model (7) are displayed in Table 3. The posterior
means of the longitude (i) and latitude (j) coefficients
indicated that the probability of a farm being BTV-8
infected decreased significantly from west to east and
increased significantly from south to north. Similarly
to the regional analysis, the posterior mean of the vac-
cination coverage was non-significantly negative and
the effect of surveillance intensity was significantly
positive. 
In a second model (8), the altitude of the farm loca-
tion was added to the linear spatial trend model to
Table 3. The estimated posterior mean and 95% posterior credible interval, given as the estimated 2.5% and 97.5% quantiles, of
the vaccination coverage (β1), surveillance intensity (β2), effect of longitude (β4) and effect of latitude (β5) of the geoadditive lin-
ear spatial trend model, without (model 7) and with (model 8) the effect of altitude (β3). 
Geoadditive model (7) Geoadditive model including  altitude (8)
2.5% Mean 97.5% 2.5% Mean 97.5%
β1
β2
β3
β4
β5
-0.99
6.38
-
-0.04
0.004
-0.06
8.26
-
-0.02
0.03
1.01
11.08
-
-0.01
0.06
-1.09
6.42
-1.58
-0.04
-0.01
-0.16
8.31
-0.71
-0.02
0.02
0.92
11.13
0.16
-0.01
0.05
Fig. 3. The estimated relative risk of the spatial model (3) at animal level (a) and farm level (b) after accounting for regional vacci-
nation coverage and surveillance intensity, plotted on an exponential scale (exp(νi + ψi)). The gray scale bar indicates the relative
risk of a unit being BTV-8 infected compared to the overall risk in Switzerland in 2008. Regions in white (GR, TI, VS, BE south)
were not considered in the analysis.
(a) (b)
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account for different temperature conditions in the
mountain areas. The posterior mean of the altitude
was negative, supporting that the probability of a unit
being BTV-8 positive decreases with increasing eleva-
tion, but the effect was not significant. Furthermore,
as is illustrated in Figure 1, the altitude and latitude
of Switzerland are highly correlated. As a conse-
quence, the effect of the latitude decreased, indicating
that the higher altitude in the Alps accounts for parts
of the decreased probability of a farm being BTV-8
infected in the south of Switzerland. The negative
effect of the vaccination coverage became slightly
stronger when adjusting for the farm altitude, while
the effect of the surveillance intensity remained simi-
lar to model (7). The DIC was lower when the farm
altitude was included as an explanatory variable
(DIC = 500.5) but the difference was negligible and,
thus, there was no strong preference for either of the
models. The residual disease risk after accounting for
all explanatory variables decreases from north-west
to south-east (Fig. 4). Hence, a trend in the spatial
risk surface could still be found after adjustment for
the altitude of the farms.
Discussion
In this study, the effect of vaccination on the region-
al and local occurrence of BTV-8 in Switzerland was
investigated. Vaccination against BTV-8 was initiated
in 2008, followed by a pronounced decrease in regis-
tered BTV-8 cases in 2009. The probability of a unit
being infected with BTV-8 was expected to be inverse-
ly correlated with vaccination coverage. Although the
results of the study point in this direction, a significant
effect of vaccination coverage on disease occurrence
was not demonstrated. 
It may seem contradictory that vaccination is a poor
explanatory variable of the probability of a unit being
BTV-8 infected. There is an established association
between vaccination and the occurrence and spread of
infection, and vaccination is an important tool in the
control of BT (Caporale et al., 2004; EC, 2009).
Nevertheless, in the Alps, there were large areas with
a low vaccination coverage as well as a low prevalence
of BTV-8. Within the geoadditive model, the effect of
vaccination coverage became stronger when the farm
altitude was accounted for, suggesting that other fac-
tors than solely vaccination influence the probability
of a unit being infected with BTV-8. For instance,
Szmaragd et al. (2010b) showed that both the vacci-
nation coverage and temperature significantly affect
the range of an outbreak.
Additionally, the government prioritised vaccination
of areas with a history of BTV-8 outbreaks. Such spa-
tially targeted vaccination could obscure any existing
correlation between vaccination coverage and disease
prevalence since the vaccination coverage becomes
higher in areas with an elevated underlying disease
risk. It is also possible that the vaccine uptake
increased with proximity to the affected area as pre-
sumed infection risk may affect the motivation of ani-
mal keepers to vaccinate their livestock (Elbers et al.,
2010). 
As the analysis was limited to annual time periods,
different levels of population susceptibility and dis-
ease occurrence throughout the year were not consid-
ered. In 2008, the vaccination campaign was not ini-
tiated until June and the vaccination of many animals
was delayed since they were on summer pasture in the
Alps (EC, 2009; FVO, 2009). Cattle receive two vac-
cine doses 3 to 9 weeks apart, followed by an esti-
mated delay of 3 weeks to reach full protection
(Gethmann et al., 2009). Thus, animals considered
vaccinated may not have attained full protection
against BTV-8 until later in the vector active season.
In regions of Italy where mass vaccination against
BTV-2 and BTV-9 was not achieved before the start of
a new epidemic, vaccination did not significantly
reduce disease occurrence, while the spread of infec-
tion and disease occurrence decreased significantly in
regions with a high vaccination coverage before the
start of a new epidemic (Caporale et al., 2004). 
Disease outbreaks may appear clustered as a con-
sequence of spatial heterogeneity in surveillance
efforts (Kluiters et al., 2008; Birch et al., 2009; Del
Fig. 4. The estimated relative linear spatial trend obtained from
the geoadditive linear spatial trend model (8), adjusted for vac-
cination coverage, surveillance intensity and altitude. The rela-
tive risk ranges from 0.1 (black) to 6.0 (white). The boundary of
Switzerland is plotted as an indication of the area under obser-
vation.
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Rio Vilas and Pfeiffer, 2009). To reduce surveillance
bias, surveillance intensity was included in the model
as an explanatory variable. At farm level, case detec-
tion was clearly correlated with surveillance intensi-
ty, supporting that spatial heterogeneity in surveil-
lance intensity needs to be considered when assessing
spatial occurrence of disease at a national level
(Kluiters et al., 2008). The model did not find any
significant association between the detection of BTV-
8 infected cattle and surveillance intensity, possibly
due to a lower surveillance intensity at animal level
than farm level.
After accounting for vaccination coverage and sur-
veillance intensity, the probability of a farm being
infected with BTV-8 increased significantly from east
to west and south to north of Switzerland. The
observed spatial effect could be related to several eco-
logical factors, such as vector presence and activity,
temperature, host density and the disease situation in
neighbouring countries. Local environmental condi-
tions and microclimate affect the presence of midges,
and the abundance of Culicoides midges varies signif-
icantly between different regions of Switzerland
(Cagienard et al., 2006; Casati et al., 2009). Due to
the environmental conditions, north and northwest of
Switzerland is more suitable for Culicoides habitation
(Racloz et al., 2007, 2008). The lower relative risk of
BTV-8 infection in the south of Switzerland was
explained, at least partly, by the higher altitude in the
mountain area in the south, and the effect of the lati-
tude became non-significant when the altitude was
adjusted for in the model. This agrees with previous
studies where lower BTV prevalence was observed at
higher elevations in otherwise endemic zones (Ward
and Carpenter, 1996) and could be related to a short-
er vector active season at higher altitudes (EFSA,
2007) as well as temperature dependent characteris-
tics of vector behaviour and viral replication (Ward
and Carpenter, 1996). The northwest of Switzerland
is also the most livestock dense area. Simulation stud-
ies of BTV spread in Scotland (Szmaragd et al.,
2010a) showed that the spatial risk of a holding being
BTV-8 infected was associated with livestock and
farm densities, where areas of high animal densities
allow for onward transmission whereas spread of
infection is limited in regions with lower livestock
densities. 
The maps of residual spatial variation are represen-
tations of the relative risk of a unit being BTV-8
infected in a defined area relative to the overall risk in
Switzerland (Fig. 3). Nevertheless, Bayesian hierarchi-
cal models assume a constant spatial and temporal
risk within each region and timeframe. However, the
spatial and spatio-temporal divisions may not coin-
cide with changes in disease risk (Pascutto et al.,
2000). Since BT is a vector-borne, transboundary dis-
ease, BTV-8 prevalence and achieved vaccination cov-
erage in neighbouring countries may also influence
the relative disease risk in Switzerland. In 2008, the
French vaccination coverage for BTV-8 was low
(36%), which led to further spread of the disease (EC,
2009) and could contribute to a higher relative dis-
ease risk in the west of Switzerland. In Germany, on
the other hand, a national vaccination coverage of
85% was attained with a substantial reduction in dis-
ease cases (EC, 2009). Nevertheless, these are nation-
al figures and may not be representative for areas bor-
dering Switzerland. In Austrian regions adjacent to
Switzerland, the vaccination coverage was also high,
and in Italy, BTV-8 infection was secluded to a limit-
ed area with a vaccination coverage considered to be
satisfactory (EC, 2009), reducing any potential spread
of BTV-8 into Switzerland from the east or south.
The role of susceptible species apart from cattle in
the maintenance and spread of BTV-8 was not con-
sidered. The level of infection in other susceptible
populations and vaccination coverage in sheep and
goats could affect the relative risk of BTV-8 infection
observed in cattle. For instance, wildlife could act as
a potential reservoir for BTV-8 (Szmaragd et al.,
2010a). Thus, vaccination data and BTV-8 prevalence
in other ruminants should ideally be included in
future studies. 
Conclusion
This paper has outlined the application of spatial
Bayesian hierarchical models to assess the relative
disease risk of BTV-8 at a national level and the effect
of vaccination as a method of control of BTV-8. By
combining data from different surveillance paths
with ecological factors, estimates of relative disease
risk were obtained, allowing disease control efforts
to be targeted to high risk areas. This is especially a
priority in countries where resources available for
disease control are limited. Examination of the spa-
tial correlation between disease occurrence, control
measures and associated ecological factors is valu-
able in the evaluation and development of disease
control programmes. Especially for diseases with sev-
eral plausible control strategies, the method could be
adapted to evaluate and compare the effect of alter-
native control measures and serve as a basis in poli-
cy development.
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